Not independent
Tenure on this board
8.1 yrs
Also a director at
4D Molecular Therapeutics Inc (FDMT)
2 nominees · 5 ballot items.
Election of two Class III directors; Ratification of KPMG LLP as independent auditors; Approval of the 2020 Equity Incentive Plan as amended and restated; Advisory vote to approve named executive officer compensation (say-on-pay); Advisory vote on frequency of future say-on-pay votes.
Elect two Class III directors (Jacob M. Chacko, M.D. and Mardi C. Dier) to serve until the 2029 annual meeting.
Ratify KPMG LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.
Approve amendments to the 2020 Plan to (i) modify the Evergreen provision reducing annual increase from 5% to 4% and removing numerical cap, (ii) specify an ISO cap of 10,000,000 shares, and (iii) eliminate administrator authority to implement an Exchange Program (repricing/exchange of awards) without stockholder approval.
Non-binding, advisory approval of the compensation of the named executive officers as disclosed in the proxy statement.
Non-binding advisory vote to select frequency (every 1, 2, or 3 years) for future advisory votes on named executive officer compensation; board recommends every year.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Nextech Invest, Ltd. | 6.92% | 7,162,637 | $91M |
| 2 | EcoR1 Capital, LLC | 6.50% | 6,728,116 | $85M |
| 3 | VIKING GLOBAL INVESTORS LP | 5.63% | 5,824,533 | $74M |
| 4 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.11% | 5,285,130 | $67M |
| 5 | PFIZER INC | 4.62% | 4,780,401 | $58M |
| 6 | SR ONE CAPITAL MANAGEMENT, LP | 4.36% | 4,514,929 | $58M |
| 7 | Venrock Adviser, LLC | 4.17% | 4,319,765 | $55M |
| 8 | NEA Management Company, LLC | 3.98% | 4,118,621 | $52M |
| 9 | ALKEON CAPITAL MANAGEMENT LLC | 3.62% | 3,751,818 | $48M |
| 10 | STATE STREET CORP | 3.58% | 3,702,196 | $47M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.